Literature DB >> 96473

Haloperidol and lithium blocking of the mood response to intravenous methylphenidate.

D Wald, R P Ebstein, R H Belmaker.   

Abstract

The euthymic manic-d-pressive patients with therapeutic plasma lithium levels were each given two i.f. infusions of 30 mg of methylphenidate. The infusions were separated by at least 3 days. Before one infusion each patient was given 5 mg of haloperidol i.v. and before the other infusion each was given an identical volume of saline. A psychiatric observer was blind to the nature of the pretreatment and the order of pretreatment was randomized. Saline pretreated patients showed marked activation and euphoriant responses despite therapeutic lithium levels. Haloperidol pretreatment reduced this response in three patients and eliminated the euphoriant and activating response in the remaining seven patients. These results agree with the existence of a dopaminergic step in the induction of methylphenidate-induced activation and euphoria.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 96473     DOI: 10.1007/bf00426962

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  22 in total

1.  Thphenidate.

Authors:  R Kadouch; R H Belmaker; R P Ebstein; L Peres
Journal:  Neuropsychobiology       Date:  1977       Impact factor: 2.328

2.  Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment.

Authors:  D P Van Kammen; D L Murphy
Journal:  Psychopharmacologia       Date:  1975-11-21

3.  Some aspects of the mechanism of action of various stimulant amphetamine analogues.

Authors:  J Scheel-Krüger
Journal:  Psychiatr Neurol Neurochir       Date:  1972 May-Jun

4.  Amphetamine effects in man: paradoxical drowsiness and lowered electrical brain acitivity (CNV).

Authors:  J J Tecce; J O Cole
Journal:  Science       Date:  1974-08-02       Impact factor: 47.728

Review 5.  The catecholamine hypothesis of affective disorders: a review of supporting evidence.

Authors:  J J Schildkraut
Journal:  Am J Psychiatry       Date:  1965-11       Impact factor: 18.112

6.  Inhibition of d-amphetamine-induced locomotor activity by injection of haloperidol into the nucleus accumbens of the rat.

Authors:  A J Pijnenburg; W M Honig; J M Van Rossum
Journal:  Psychopharmacologia       Date:  1975

7.  Lithium and alpha-methyl-p-tyrosine prevent "manic" activity in rodents.

Authors:  C Davies; D J Sanger; H Steinberg; M Tomkiewicz; D C U'Prichard
Journal:  Psychopharmacologia       Date:  1974-04-23

8.  Blockade of intravenous amphetamine euphoria in man.

Authors:  L E Jönsson; E Anggård; L M Gunne
Journal:  Clin Pharmacol Ther       Date:  1971 Nov-Dec       Impact factor: 6.875

9.  Lithium: effects on subjective functioning and morphine-induced euphoria.

Authors:  D R Jasinski; J G Nutt; C A Haertzen; J D Griffith; W E Bunney
Journal:  Science       Date:  1977-02-11       Impact factor: 47.728

10.  The effect of haloperidol on epinephrine-stimulated adenylate cyclase in humans.

Authors:  R H Belmaker; R P Ebstein; H Schoenfeld; R Rimon
Journal:  Psychopharmacology (Berl)       Date:  1976-09-17       Impact factor: 4.530

View more
  8 in total

Review 1.  [New insights into the pathogenesis and pathophysiology of depression].

Authors:  C Schüle; T C Baghai; R Rupprecht
Journal:  Nervenarzt       Date:  2007-11       Impact factor: 1.214

2.  Effects of lithium carbonate on methylphenidate-induced mood, behavior, and cognitive processes.

Authors:  L Y Huey; D S Janowsky; L L Judd; A Abrams; D Parker; P Clopton
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

Review 3.  Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder.

Authors:  J S Markowitz; K S Patrick
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

4.  Major depression in Parkinson's disease and the mood response to intravenous methylphenidate: possible role of the "hedonic" dopamine synapse.

Authors:  R Cantello; M Aguggia; M Gilli; M Delsedime; I Chiardò Cutin; A Riccio; R Mutani
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

5.  Mood responses of remitted schizophrenics to methylphenidate infusion.

Authors:  D Robinson; D Mayerhoff; J Alvir; T Cooper; J Lieberman
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

6.  Provocative tests with psychostimulant drugs in schizophrenia.

Authors:  J A Lieberman; J M Kane; J Alvir
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

7.  Lithium attenuates the activation-euphoria but not the psychosis induced by d-amphetamine in schizophrenia.

Authors:  D P van Kammen; J P Docherty; S R Marder; J E Rosenblatt; W E Bunney
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

8.  c-di-GMP modulates type IV MSHA pilus retraction and surface attachment in Vibrio cholerae.

Authors:  Kyle A Floyd; Calvin K Lee; Wujing Xian; Mahmoud Nametalla; Aneesa Valentine; Benjamin Crair; Shiwei Zhu; Hannah Q Hughes; Jennifer L Chlebek; Daniel C Wu; Jin Hwan Park; Ali M Farhat; Charles J Lomba; Courtney K Ellison; Yves V Brun; Javier Campos-Gomez; Ankur B Dalia; Jun Liu; Nicolas Biais; Gerard C L Wong; Fitnat H Yildiz
Journal:  Nat Commun       Date:  2020-03-25       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.